For a more in-depth look at this topic, you may be interested in participating in the third masterclass of our Healthtech Reimbursement Program – Bringing it all together: translating reimbursement and health economics to successful market adoption.

In today’s value-based environment, the commercial challenges are more numerous than ever, and regulatory approval alone does not guarantee market adoption and success. To mitigate risk, preserve capital, and ensure the most efficient path to commercial success, these functions need to be aligned around an integrated strategy.

This seminar will explore integrated approaches to research and development, clinical, regulatory, quality, and commercial interests to ensure the most efficient path to commercial success for health and medical technologies.

Speaker: Dr Daniel Lace, Physician, Reimbursement Strategist, NAMSA

Date: Tuesday 27 August
Time: 3.45 pm registration, presentation & discussion 4.00 pm – 5.00 pm, followed by networking until 6.00 pm
Venue: Phillips Ormonde Fitzpatrick – 16/333 Collins St, Melbourne VIC 3000

Cost:
BioMelbourne Network Members: $65 (incl. GST)
Non Members: $130 (incl. GST)

Check if your organisation is a member

Note: Participants registered for the third masterclass of the Healthtech Reimbursement program will receive three registrations for this event.

Cancellation policy:
A full refund is given up to 7 days prior to the event. No refunds within 7 days of the event.

Event Supporter:

Event Host:

 

 

 

About our speaker

Daniel Lace is the Chief Medical Officer of Leaders in Medicine. His experience is at the convergence of managed markets, disease and outcome management, and new medical technologies and services.

Dr Lace provides in-depth market analysis for devising payer and purchaser strategies, design and optimisation of health management programs and introduction and integration of new products and services.

He provides real-world experience in developing evidence generation strategies to demonstrate value for products and technologies. He provides expertise in market introduction and integration of new medical technologies, products and services to manage healthcare utilisation, quality and costs.

Dr Lace has over 25 years of leadership experience as a healthcare executive across a wide range of managed care, pharmaceutical, device, diagnostic and consulting businesses. He has served as Chief Medical Officer and has held senior leadership positions in global pharmaceutical and device companies, as well as in national managed care organisations.

In addition to being a frequent national speaker and educator on managed care programs and emerging medical technologies, Dr Lace has authored numerous articles and has served on the boards of directors, medical advisory boards, editorial boards and expert panels for multiple healthcare entities.